NASDAQ:INMD InMode (INMD) Stock Price, News & Analysis $17.89 +0.29 (+1.65%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$17.45▼$17.9150-Day Range$16.82▼$19.6252-Week Range$16.44▼$48.25Volume562,461 shsAverage Volume1.44 million shsMarket Capitalization$1.50 billionP/E Ratio8.48Dividend YieldN/APrice Target$28.83 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestTrends Get InMode alerts: Email Address InMode MarketRank™ Stock AnalysisAnalyst RatingHold2.29 Rating ScoreUpside/Downside61.2% Upside$28.83 Price TargetShort InterestBearish9.41% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.40Based on 13 Articles This WeekInsider TradingN/AProj. Earnings Growth8.15%From $1.35 to $1.46 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.65 out of 5 starsMedical Sector489th out of 936 stocksElectromedical Equipment Industry11th out of 22 stocks 3.1 Analyst's Opinion Consensus RatingInMode has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on 2 buy ratings, 5 hold ratings, and no sell ratings.Amount of Analyst CoverageInMode has only been the subject of 4 research reports in the past 90 days.Read more about InMode's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.41% of the outstanding shares of InMode have been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in InMode has recently increased by 0.89%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldInMode does not currently pay a dividend.Dividend GrowthInMode does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INMD. Previous Next 2.4 News and Social Media Coverage News SentimentInMode has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 13 news articles for InMode this week, compared to 6 articles on an average week.Search InterestOnly 16 people have searched for INMD on MarketBeat in the last 30 days. This is a decrease of -6% compared to the previous 30 days.MarketBeat Follows8 people have added InMode to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InMode insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.92% of the stock of InMode is held by insiders.Percentage Held by Institutions68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InMode's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for InMode are expected to grow by 8.15% in the coming year, from $1.35 to $1.46 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InMode is 8.48, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 143.26.Price to Earnings Ratio vs. SectorThe P/E ratio of InMode is 8.48, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 169.33.Price to Book Value per Share RatioInMode has a P/B Ratio of 2.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about InMode's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About InMode Stock (NASDAQ:INMD)InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.Read More INMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INMD Stock News HeadlinesJuly 25 at 8:15 AM | prnewswire.comDOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender OfferJuly 25 at 4:36 AM | msn.comJefferies Downgrades InMode (INMD)July 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 25 at 3:26 AM | americanbankingnews.comInMode (INMD) Set to Announce Earnings on ThursdayJuly 24 at 12:15 PM | americanbankingnews.comInMode (NASDAQ:INMD) Cut to Hold at Jefferies Financial GroupJuly 19, 2024 | finanznachrichten.deInMode Ltd.: Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency MicroneedlingJuly 19, 2024 | markets.businessinsider.comInMode Gets FDA Clearance For Morpheus8, First FRF Microneedling Tech For Soft Tissue ContractionJuly 18, 2024 | americanbankingnews.comTraders Purchase Large Volume of InMode Call Options (NASDAQ:INMD)July 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 17, 2024 | prnewswire.comMorpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency MicroneedlingJuly 11, 2024 | prnewswire.comInMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024July 1, 2024 | investorplace.com3 MedTech Stocks to Buy for Healthy GainsJune 13, 2024 | seekingalpha.comInMode: Reversing Previous Shareholder Dilution With BuybacksMay 16, 2024 | prnewswire.comInMode to Present at Jefferies Healthcare ConferenceMay 8, 2024 | msn.comInMode, Driver Ink DealMay 8, 2024 | prnewswire.comInMode Announces P1 Offshore Racing Partnership with Female Driver Victoria RandMay 8, 2024 | seekingalpha.comInMode: Facing A Myraid Of HeadwindsMay 4, 2024 | finance.yahoo.comInMode Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting NowSee More Headlines Receive INMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Today7/26/2024Next Earnings (Confirmed)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:INMD CUSIPN/A CIK885988 Webwww.inmodemd.com Phone972-4909-7470FaxN/AEmployees581Year Founded2008Price Target and Rating Average Stock Price Target$28.83 High Stock Price Target$61.00 Low Stock Price Target$16.00 Potential Upside/Downside+61.2%Consensus RatingHold Rating Score (0-4)2.29 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)$2.11 Trailing P/E Ratio8.48 Forward P/E Ratio13.25 P/E GrowthN/ANet Income$197.92 million Net Margins38.84% Pretax MarginN/A Return on Equity26.15% Return on Assets23.83% Debt Debt-to-Equity RatioN/A Current Ratio13.45 Quick Ratio12.66 Sales & Book Value Annual Sales$492.05 million Price / Sales3.05 Cash Flow$2.24 per share Price / Cash Flow8.00 Book Value$6.68 per share Price / Book2.68Miscellaneous Outstanding Shares83,980,000Free Float78,170,000Market Cap$1.50 billion OptionableOptionable Beta2.18 Social Links 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Yair Malca (Age 46)Chief Financial Officer Comp: $581kMs. Nava Tal-LaunerChief Information OfficerMr. Shakil Lakhani (Age 41)President of North America Comp: $3.49MMr. Moshe Mizrahy (Age 71)Chairman & CEO Comp: $216kMr. Alon YaariVice President of OperationsDr. Michael Kreindel (Age 56)CTO & Director Comp: $221kDr. Spero Theodorou M.D. (Age 52)Chief Medical Officer Comp: $1.84MMore ExecutivesKey CompetitorsNatus MedicalNASDAQ:NTUSMasimoNASDAQ:MASITransMedics GroupNASDAQ:TMDXIntegerNYSE:ITGRLivaNovaNASDAQ:LIVNView All CompetitorsInstitutional OwnershipBank of New York Mellon CorpBought 31,549 shares on 7/26/2024Ownership: 0.332%ARK Investment Management LLCBought 32,369 shares on 7/26/2024Ownership: 0.149%North Growth Management Ltd.Bought 63,000 shares on 7/25/2024Ownership: 0.706%Easterly Investment Partners LLCSold 11,000 shares on 7/25/2024Ownership: 0.114%Perfromance Wealth Partners LLCSold 1,000 shares on 7/22/2024Ownership: 0.017%View All Institutional Transactions INMD Stock Analysis - Frequently Asked Questions How have INMD shares performed this year? InMode's stock was trading at $22.24 on January 1st, 2024. Since then, INMD shares have decreased by 19.6% and is now trading at $17.89. View the best growth stocks for 2024 here. How were InMode's earnings last quarter? InMode Ltd. (NASDAQ:INMD) released its quarterly earnings data on Thursday, May, 2nd. The healthcare company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.09. The healthcare company had revenue of $80.28 million for the quarter, compared to analyst estimates of $80.10 million. InMode had a net margin of 38.84% and a trailing twelve-month return on equity of 26.15%. When did InMode's stock split? InMode's stock split on Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly created shares were distributed to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What is Moshe Mizrahy's approval rating as InMode's CEO? 1 employees have rated InMode Chief Executive Officer Moshe Mizrahy on Glassdoor.com. Moshe Mizrahy has an approval rating of 100% among the company's employees. This puts Moshe Mizrahy in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. Does InMode have any subsidiaries? The following companies are subsidiaries of InMode: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd.. When did InMode IPO? InMode (INMD) raised $75 million in an initial public offering on Thursday, August 8th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Barclays, UBS Investment Bank and Canaccord Genuity served as the underwriters for the IPO and Baird was co-manager. Who are InMode's major shareholders? Top institutional investors of InMode include Boston Trust Walden Corp (1.72%), North Growth Management Ltd. (0.71%), Bank of New York Mellon Corp (0.33%) and ARK Investment Management LLC (0.15%). How do I buy shares of InMode? Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of InMode own? Based on aggregate information from My MarketBeat watchlists, some other companies that InMode investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD) and Block (SQ). This page (NASDAQ:INMD) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
